Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Apr 22, 2025 | 11.33 | +5.10 |
Oak Valley Bancorp | OVLY | Apr 22, 2025 | 24.89 | +5.51 |
Oak Woods Acquisition | OAKU | Apr 22, 2025 | 11.69 | 0.00 |
Oaktree Acquisition III Life Sciences | OACC | Apr 22, 2025 | 10.07 | -0.06 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Apr 22, 2025 | 10.31 | 0.00 |
Oaktree Capital A Pref | OAK-A | Apr 22, 2025 | 20.36 | +0.30 |
Oaktree Capital Group B Pref | OAK-B | Apr 22, 2025 | 20.20 | -0.29 |
Oaktree Specialty | OCSL | Apr 22, 2025 | 14.23 | +1.07 |
Oatly ADR | OTLY | Apr 22, 2025 | 8.68 | +1.76 |
Oblong | OBLG | Apr 22, 2025 | 3.54 | +65.42 |
Occidental Petroleum | OXY | Apr 22, 2025 | 39.97 | +2.43 |
Ocean Biomedical | OCEA | Apr 22, 2025 | 0.04 | -3.75 |
Ocean Power Technologies | OPTT | Apr 22, 2025 | 0.39 | +3.98 |
Oceaneering International | OII | Apr 22, 2025 | 17.38 | -0.23 |
OceanFirst Financial | OCFC | Apr 22, 2025 | 16.22 | +3.12 |
OceanFirst Pref | OCFCP | Apr 22, 2025 | 25.35 | +0.07 |
OceanPal | OP | Apr 22, 2025 | 0.69 | -0.29 |
Ocugen | OCGN | Apr 22, 2025 | 0.69 | +1.54 |
Ocular Therapeutix | OCUL | Apr 22, 2025 | 7.91 | +3.94 |
Oculis | OCS | Apr 22, 2025 | 17.78 | -1.88 |
Oddity Tech | ODD | Apr 22, 2025 | 41.53 | +1.79 |
Odysight.ai | ODYS | Apr 22, 2025 | 5.31 | 0.00 |
Odyssey Marine Exploration | OMEX | Apr 22, 2025 | 0.46 | +8.69 |
Offerpad Solutions A | OPAD | Apr 22, 2025 | 1.40 | -3.45 |
Office Properties | OPI | Apr 22, 2025 | 0.33 | -2.44 |
OFG Bancorp | OFG | Apr 22, 2025 | 36.35 | +2.60 |
OFS Capital | OFS | Apr 22, 2025 | 8.40 | +0.96 |
OFS Credit | OCCI | Apr 22, 2025 | 6.48 | +3.18 |
OFS Credit C Pref | OCCIO | Apr 22, 2025 | 24.46 | -0.16 |
OFS Credit Company Pref F | OCCIM | Apr 22, 2025 | 24.26 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.